PRTAProthena Corporation plc Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $10.04 (+0.00% today)

Market Cap: $540.48M

P/E (TTM): -2.20

Forward P/E (FY1): 40.70

EPS Growth: -435.1%

Analyst Upside: 89.2%

Relative Strength (RS%): 33

-14.1% from 52-week high

Back to Scanner

PRTA

NASDAQRS 33Score 40

Prothena Corporation plc

HealthcareBiotechnology$540.48M2 setups passing
$10.04
0.0% ($0.00)
-14.1% from 52W High
P/E (TTM)
-2.20
Fwd P/E
40.70
PEG
0.39
Analyst Upside
+89.2%
EPS Growth
-435.1%
Gross Margin
-208.6%
ROE
-73.0%
D/E
0.05
Div Yield
0.0%
Avg Volume
412.5K

Price Chart

Key Levels

SMA 200
$8.90
SMA 50
$9.19
Price
$10.04
52W High
$11.69
Target
$19.00

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst